Fibroma - 265 Studies Found
Completed |
: Imatinib Mesylate in Treating Patients With Recurrent or Refractory Fibromatosis : Desmoid Tumor : 2006-02-06 : Drug: imatinib mesylate |
Completed |
: Radiation Therapy in Treating Patients With Aggressive Fibromatoses : Desmoid Tumor : 2002-02-14 : Radiation: radiation therapy |
Recruiting |
: National Clinical-biological Prospective Cohort of Incident Cases of Aggressive Fibromatosis (ALTITUDES) : Aggressive Fibromatosis : 2016-07-15 :
|
Active, not recruiting |
: A Trial of Imatinib for Patients With Aggressive Desmoid Tumor (Aggressive Fibromatosis) : Fibromatosis : 2015-07-08 : Drug: Imatinib Imatinib 400 mg/day until disease progression |
Recruiting |
: 18F-FES PET/CT in Imaging Patients With Desmoid Tumors :
: 2015-02-16 :
|
Recruiting |
: Allogenic Mesenchymal Stem Cell for Bone Defect or Non Union Fracture :
: 2014-10-07 : Biological: MSC subjects are implanted with allogenic mesenchymal stem cells from umbilical cord/ bone m |
Active, not recruiting |
: Phase II Trial of the Gamma-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors/Aggressive Fibromatosis :
: 2013-10-31 : Drug: PF-03084014 Treatment with the selective small-molecule >=-secretase inhibitor PF- 3084014 caus |
Completed |
: Study to Evaluate Imatinib in Desmoid Tumors :
: 2010-06-02 : Drug: Imatinib 800 mg Other Name: Glivec |
Active, not recruiting |
: A Phase 2, Study to Evaluate the Safety and Efficacy Proellex® (Telapristone Acetate) Administered Vaginally in the Treatment of Uterine Fibroids : Uterine Fibroids : 2014-12-18 :
|
Recruiting |
: Prospective Trial Comparing the Performance Profiles of Two Non-Cross-Linked Porcine Dermal Matrices in Abdominal Wall Reconstruction :
|